Medicamen Organics Ltd Quarterly Results, Profit & Loss, Balance Sheet (MEDIORG) | Stocksigma

Medicamen Organics Ltd (MEDIORG) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Medicamen Organics Ltd reported sales of ₹17.85 Cr, operating profit of ₹3.42 Cr (OPM 19.16%) and net profit of ₹2.04 Cr for the quarter ended Sep 2025. Figures in ₹ crore, consolidated where available.

MEDIORG quarterly results (₹ Cr)
Metric	Mar 2024	Sep 2024	Mar 2025	Sep 2025
Sales	13.95	16.61	21.58	17.85
Expenses	11.62	13.88	17.73	14.43
Operating Profit	2.33	2.73	3.85	3.42
OPM	16.7%	16.44%	17.84%	19.16%
Other Income	0.01	0.04	0.05	0.06
Interest	0.36	0.22	0.29	0.33
Depreciation	0.36	0.36	0.37	0.41
Profit before tax	1.62	2.19	3.24	2.74
Tax	22.84%	30.59%	21.6%	25.55%
Net Profit	1.26	1.51	2.54	2.04
EPS in Rs	1.47	1.29	2.17	1.74

MEDIORG profit & loss, annual (₹ Cr)
Metric	Mar 2024	Mar 2025	TTM
Sales	25.27	38.19	39.43
Expenses	20.53	31.58	32.16
Operating Profit	4.74	6.61	7.27
OPM	18.76%	17.31%	18.44%
Other Income	1.07	0.1	0.11
Interest	0.65	0.54	0.62
Depreciation	0.72	0.74	0.78
Profit before tax	4.44	5.43	5.98
Tax	40.77%	25.41%	-
Net Profit	2.62	4.05	4.58
EPS in Rs	3.05	3.46	3.91
Dividend Payout	0%	0%	-

MEDIORG balance sheet (₹ Cr)
Metric	Mar 2024	Mar 2025	Sep 2025
Equity Capital	8.6	11.7	11.7
Reserves	6.66	18.43	20.92
Borrowings	12.66	12.35	15.67
Other Liabilities	10.52	16.73	12.86
Total Liabilities	38.44	59.21	61.15
Fixed Assets	10.35	10.13	12.79
CWIP	0.15	2.22	0.36
Investments	0	0	0
Other Assets	27.94	46.86	48
Total Assets	38.44	59.21	61.15

MEDIORG cash flows (₹ Cr)
Metric	Mar 2024	Mar 2025
Cash from Operating Activity	-3.66	-4.54
Cash from Investing Activity	-0.34	-2.35
Cash from Financing Activity	4.01	10.47
Net Cash Flow	0.01	3.58
Free Cash Flow	-4.01	-6.99
CFO/OP	-73%	-67%

MEDIORG ratios
Metric	Mar 2024	Mar 2025
Debtor Days	241.21	247.06
Inventory Days	244.39	228.39
Days Payable	281.81	356.77
Cash Conversion Cycle	203.8	118.69
Working Capital Days	74.24	135.14
ROCE	-	16.88%